ArticleDiabetology & metabolic syndrome2025

Empagliflozin targeted the immune-related gene PIK3CA in type 2 diabetes mellitus treatment: network pharmacology analysis and experimental evidence.

Heng Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.